| __timestamp | Ligand Pharmaceuticals Incorporated | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 22570000 | 1244910 |
| Thursday, January 1, 2015 | 24378000 | 5029636 |
| Friday, January 1, 2016 | 26621000 | 4846776 |
| Sunday, January 1, 2017 | 28653000 | 5329003 |
| Monday, January 1, 2018 | 37734000 | 7121000 |
| Tuesday, January 1, 2019 | 41884000 | 9128000 |
| Wednesday, January 1, 2020 | 64435000 | 10731000 |
| Friday, January 1, 2021 | 57483000 | 10701000 |
| Saturday, January 1, 2022 | 70062000 | 16121000 |
| Sunday, January 1, 2023 | 52790000 | 37021000 |
Cracking the code
In the competitive landscape of biotechnology, operational efficiency is paramount. Over the past decade, Ligand Pharmaceuticals Incorporated and Viking Therapeutics, Inc. have showcased contrasting trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Ligand's SG&A expenses have seen a steady increase, peaking in 2022 with a 210% rise from 2014. In contrast, Viking Therapeutics, starting with a modest base, experienced a dramatic surge, culminating in a 2,870% increase by 2023. This divergence highlights Ligand's consistent operational scaling, while Viking's rapid growth reflects its aggressive market expansion strategy. As the biotech sector evolves, understanding these financial dynamics offers valuable insights into each company's strategic priorities and market positioning.
Comparing SG&A Expenses: Bristol-Myers Squibb Company vs Viking Therapeutics, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Ligand Pharmaceuticals Incorporated
SG&A Efficiency Analysis: Comparing Biogen Inc. and Ligand Pharmaceuticals Incorporated
SG&A Efficiency Analysis: Comparing Ascendis Pharma A/S and Viking Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Blueprint Medicines Corporation and Viking Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Ligand Pharmaceuticals Incorporated
Who Optimizes SG&A Costs Better? Alpine Immune Sciences, Inc. or Ligand Pharmaceuticals Incorporated
Who Optimizes SG&A Costs Better? Viking Therapeutics, Inc. or Xenon Pharmaceuticals Inc.
Viking Therapeutics, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Viking Therapeutics, Inc. and Wave Life Sciences Ltd.
Cost Management Insights: SG&A Expenses for Amicus Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
Comparing SG&A Expenses: Ligand Pharmaceuticals Incorporated vs Iovance Biotherapeutics, Inc. Trends and Insights